| EXENATIDE SYNTHETIC | Astrazeneca | ||
| 2MG/0.85ML ; SUSPENSION,EXTENDED RELEASE |
Less Than $1000 mn
|
||
| None | None | ||
|
Less Than 5
|
None | ||
| None | None | ||
| BYDUREON BCISE is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus. | |||
|
Yes
| |||
| BYDUREON BCISE | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 | Patent 22 | Patent 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||||||
| *** ** ******** *** *** ********* ** **** ****** | ******** *** ******* ******** *** ****** ********* *** ******* | ******* *** ******** *********** | *********** ** ********** *********** ****** ******** ************* | ******* *** *** *********** ** *******-***** ********* ******* ************ | *-**** ********* ***** ********** *** ****** | *-**** ********* ***** ********** *** ****** | ************** ************ ********** ** ***** ********* | ******** ******* ********** ****** *** ************** ******** ******* | ******** ******* ********** ****** *** ************** ******** ******* | *******-***** ********* ******* ****** | *******-***** ********* ******* ****** | *******-***** ********* ******* ****** | *******-***** ********* ******* ****** | *******-***** ********* ******* ****** | *******-***** ********* ******* ****** | *-**** ********* ***** ********** *** ****** | ******* *** ******** ******** *** ******** **** ****** | ****** *** ******** ******** | ******* *** ******** ******** *** ******** **** ****** | ******* ********** ** ***** ********** *** ********* *** ********* **** | ************** ************ ********** ** ***** ********* | ********* ******* ************ ***** ***-******* ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|